UnitedHealth Group (NYSE:UNH) Given “Hold” Rating at TD Securities

UnitedHealth Group (NYSE:UNH)‘s stock had its “hold” rating reaffirmed by analysts at TD Securities in a report issued on Monday,Benzinga reports. They currently have a $308.00 price target on the healthcare conglomerate’s stock, down from their previous price target of $520.00. TD Securities’ price target indicates a potential downside of 1.21% from the company’s current price.

Other equities analysts have also issued reports about the stock. Truist Financial reiterated a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Eight investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $454.23.

UnitedHealth Group Stock Performance

Shares of UNH traded up $19.87 during mid-day trading on Monday, reaching $311.78. The company had a trading volume of 45,194,096 shares, compared to its average volume of 6,041,800. The stock has a 50 day moving average of $470.82 and a two-hundred day moving average of $513.25. The stock has a market capitalization of $282.83 billion, a P/E ratio of 20.09, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the business earned $6.91 EPS. On average, analysts expect that UnitedHealth Group will post 29.54 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO John F. Rex purchased 17,175 shares of the company’s stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company’s stock.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently made changes to their positions in UNH. Capital & Planning LLC grew its position in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after acquiring an additional 79 shares in the last quarter. My Legacy Advisors LLC increased its position in UnitedHealth Group by 1.6% during the fourth quarter. My Legacy Advisors LLC now owns 4,812 shares of the healthcare conglomerate’s stock worth $2,615,000 after buying an additional 78 shares during the last quarter. Delta Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.8% during the 4th quarter. Delta Capital Management LLC now owns 7,250 shares of the healthcare conglomerate’s stock worth $3,667,000 after acquiring an additional 60 shares in the last quarter. Brady Martz Wealth Solutions LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $978,000. Finally, Client 1ST Advisory Group LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $292,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.